Dermata Therapeutics Inc. (DRMAW)

AI Score

Unlock

0.02

-0.00 (-14.53%)

At close: Apr 17, 2025, 3:54 PM

0.02

0.00%

After-hours: Apr 17, 2025, 04:00 PM EDT

Dermata Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-3.15M	-3.17M	-2.83M	-3.13M	-2.13M	-1.72M	-1.7M	-2.24M	-1.67M	-2.42M	-2.73M	-2.79M	-2.55M	-1.71M	-1.33M	-2.3M	-396.31K	-597.39K	-821.65K	-1.42M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	322.00
Stock-Based Compensation	29.82K	20.99K	19.61K	587.23K	128.47K	131.18K	131.18K	131.26K	220.89K	234.98K	261.57K	212.88K	488.72K	142.66K	113.99K	1.16M	n/a	n/a	n/a	n/a
Other Working Capital	305.7K	-155.54K	279.81K	-157.43K	466.63K	-220.27K	-215.09K	463.08K	-389.78K	-246.6K	682.9K	-181.56K	514.85K	-528.5K	-78.7K	-29.07K	-38.57K	-542.07K	38.99K	18.71K
Other Non-Cash Items	n/a	259.36K	n/a	587.23K	128.47K	131.18K	131.18K	n/a	220.89K	234.98K	-53.42K	212.88K	488.72K	156.00	78.00	13.89K	-124.78K	16.13K	15.18K	56.98K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	207.51K	-526.12K	683.54K	-157.43K	858.2K	-183.59K	-270.18K	459.25K	-376.82K	-371.67K	629.49K	-34.58K	260.23K	-639.94K	314.51K	354.75K	-14.88K	-788.35K	62.58K	-15.2K
Operating Cash Flow	-2.91M	-3.42M	-2.13M	-2.7M	-1.15M	-1.77M	-1.84M	-1.65M	-1.83M	-2.56M	-1.84M	-2.61M	-1.8M	-2.21M	-903.21K	-776.22K	-535.97K	-1.37M	-743.89K	-1.38M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.01M	313.33K	1.37M	n/a	n/a
Common Stock Repurchased	n/a	n/a	-828	n/a	n/a	-35.42	n/a	-40	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	941.00	70.17K	-70K	n/a	n/a	n/a	34.00	193.00	4.27B	200.00	87.00	n/a	n/a	n/a	n/a	570K	n/a	18.75K	617.85K	n/a
Financial Cash Flow	-68.57K	4.62M	2.34M	n/a	1.95M	-35.42K	1.51M	4.18M	4.27B	200.00	4.28M	n/a	-626	14.39M	n/a	1.58M	313.33K	1.39M	867.85K	n/a
Net Cash Flow	-2.98M	1.2M	213.42K	-2.7M	806.65K	-1.81M	-328.23K	2.53M	-1.83M	-2.56M	2.44M	-2.61M	-1.8M	12.18M	-903.21K	800.01K	-222.65K	16.35K	123.96K	-1.38M
Free Cash Flow	-2.91M	-3.42M	-2.13M	-2.7M	-1.15M	-1.77M	-1.84M	-1.65M	-1.83M	-2.56M	-1.84M	-2.61M	-1.8M	-2.21M	-903.21K	-776.22K	-535.97K	-1.37M	-743.89K	-1.38M